Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy

Authors:

Abstract
No abstract available
Funding Information
  • Cancer Research UK (A24604)
  • Imperial Experimental Cancer Medicine Centre
  • Imperial College London
  • Medical Research Council (MC-A652-5PY80)
  • Imperial College Healthcare NHS Trust
  • NIHR Imperial Biomedical Research Centre
  • National Institute for Health and Care Research

This publication has 36 references indexed in Scilit: